说明:双击或选中下面任意单词,将显示该词的音标、读音、翻译等;选中中文或多个词,将显示翻译。
您的位置:首页 -> 词典 -> 肝细胞株L-02
1)  hepatocyte strain L-02
肝细胞株L-02
1.
Objective To establish the hepatocyte steatosis models with human hepatocyte strain L-02.
目的以人正常肝细胞株L-02为实验材料,采用油酸诱导建立培养肝细胞脂肪变性模型。
2)  L-02 strain of hepatocyte
L-02肝细胞株
3)  L-02 cell line
L-02细胞株
4)  L-02 hepatic cell
L-02肝细胞
1.
Establishment of experimental model for DNA damage tolerance induced by HQ in L-02 hepatic cells;
L-02肝细胞对氢醌所致DNA损伤耐受实验模型的初步建立
2.
Effect of hydroquinone on the expression of ubiquitin-conjugating enzyme Rad6B in human L-02 hepatic cells
氢醌对人L-02肝细胞泛素结合酶Rad6B表达的影响
3.
Methods MTT assay was used to detect the effects of HQ with various concentrations(0,5,10,20,40,80,160 and 320 μmol/L)on the survival rate of L-02 hepatic cells for 24 h.
目的探讨氢醌(HQ)对体外培养L-02肝细胞凋亡(apoptosis)的影响和HQ毒性作用的分子机制。
5)  L-02 hepatocytes
L-02肝细胞
1.
Effects of selenium on chromium(Ⅵ)-induced DNA damage in L-02 hepatocytes;
硒对六价铬诱导L-02肝细胞DNA损伤的影响
2.
Objective To explore the effect of hexavalent chromium on the energy metabolism of mitochondria in L-02 hepatocytes.
目的探讨六价铬(Cr(VI))对L-02肝细胞线粒体能量代谢的影响。
3.
Objective: To study the mitochondrial damage and the oxidative stress induced by pentachlorophenol sodium(Na-PCP)in L-02 hepatocytes,to build an experiment foundation for better understanding the toxicity of pentachlorophenol sodium(Na-PCP).
目的: 在体外试验系统(in vitro test),研究有机氯农药-五氯酚钠(Pentachlorophenol Sodium,Na-PCP)对L-02肝细胞氧化应激和线粒体损伤,为进一步了解五氯酚钠的毒作用机制奠定实验基础。
6)  L-02 hepatocyte
L-02肝细胞
1.
Objective To investigate the time-order effect of vitamin C(ascorbic acid)on antagonizing hexavalent chromium-induced L-02 hepatocyte cytotoxicity by MTT assay in vitro.
目的探讨在体外实验系统中维生素C在拮抗六价铬[Cr(Ⅵ)]诱导L-02肝细胞毒性的时序效应。
2.
Objective To investigate the oxidative stress and micro RNA expression changes of hexavalent chromium(Cr+6)induced L-02 hepatocyte in vitro.
目的通过体外实验,在细胞水平探讨六价铬[Cr(Ⅵ)]诱导的L-02肝细胞氧化应激状态及microRNA谱系的改变。
补充资料:肝复肽 ,肝细胞水解物
药物名称:肝复肽

英文名:Hepatocyte Hydrolysate

别名: 肝复肽 ,肝细胞水解物
外文名:hepatocyte hydrohysate
适应症: 重症肝炎、急性肝炎、慢性肝炎、肝硬化的辅助治疗。
用量用法: 肌肉注射:20 mg bid,一个月为一疗程。静脉注射:40-80mg qd,一个月为一疗程。
规格: 粉剂 20 mg x 5支。


类别:肝胆疾病辅助用药
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条